Chaim Lebovits | CEO |
Eyal Rubin | CFO |
Ralph Kern | CMO & COO |
Caroline Palomeque | Maxim Group |
David Bautz | Zacks Investment Research |
Good day and welcome to the BrainStorm Cell Therapeutics' Second Quarter 2018 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Paul Errant [ph]. Please go ahead.
Thank you, operator, and good morning everyone and thank you for participating in today's second quarter 2018 financial results conference call for BrainStorm Cell Therapeutics.